Visceral Pain Global Market Report 2024

Description

Visceral pain originates from internal organs such as the stomach, bladder, uterus, or rectum and can stem from factors such as inflammation, menstrual cramps, organ swelling, blockages, reduced blood flow, or tumors, particularly in the pelvis or abdomen, often accompanied by symptoms such as nausea, sweating, or increased heart rate.

The principal drug classes for treating visceral pain include calcium channel blockers (CCBs), nonsteroidal anti-inflammatories (NSAIDs), and others. CCBs regulate calcium ion movement into heart and blood vessel cells, with indications spanning interstitial cystitis, Crohn's disease, irritable bowel syndrome, chronic prostatitis, and more. These medications are employed across various end-user settings including hospitals, homecare, specialty clinics, among others.

The visceral pain market research report is one of a series of new reports from The Business Research Company that provides visceral pain market statistics, including visceral pain industry global market size, regional shares, competitors with a visceral pain market share, detailed visceral pain market segments, market trends, and opportunities, and any further data you may need to thrive in the visceral pain industry. This visceral pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The visceral pain treatment market size has grown strongly in recent years. It will grow from $12.87 billion in 2023 to $13.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including an aging population, an increased incidence of chronic diseases, advancements in medical research, the expansion of healthcare infrastructure, and rising awareness and diagnosis rates.

The visceral pain treatment market size is expected to see strong growth in the next few years. It will grow to $17.70 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The projected growth in the forecast period is driven by technological innovations in pain management, increasing demand for non-invasive treatment options, the emergence of new markets and untapped opportunities, personalized medicine approaches, and the integration of digital health solutions. Key trends expected during this period include a shift towards multimodal pain management, a growing emphasis on alternative therapies, the rise of targeted therapies tailored to specific types of pain, the expanding role of telemedicine in pain management, and the integration of artificial intelligence in pain assessment.

The anticipated surge in demand for analgesics is poised to drive the expansion of the visceral pain market in the future. Analgesics are medications designed to alleviate pain by reducing or blocking the perception of pain signals in the brain. They play a crucial role in managing visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For example, as documented by the Centers for Disease Control and Prevention (CDC) in December 2023, there was a notable increase in the total number of dispensed Buprenorphine prescriptions, an opioid analgesic, from 16,011,239 in 2020 to 16,105,318 in 2021, reflecting a significant 0.59% rise compared to the corresponding period in 2020. Consequently, the escalating demand for analgesics serves as a driving force behind the growth of the visceral pain market.

Prominent companies in the visceral pain market are dedicated to developing innovative products such as NHE3 Inhibitors to offer dependable solutions to consumers. NHE3 inhibitors constitute a class of medications that function by inhibiting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gastrointestinal tract. For example, in April 2022, Ardelyx, a US-based biopharmaceutical firm, introduced an NHE3 Inhibitor medication called IBSRELA. This groundbreaking treatment targets adults with irritable bowel syndrome with constipation (IBS-C), acting on the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. Preclinical studies have demonstrated its efficacy in reducing abdominal pain by alleviating visceral hypersensitivity and intestinal permeability.

In February 2021, Jazz Pharmaceuticals, an Irish pharmaceutical company, completed the acquisition of GW Pharmaceuticals plc for $7.2 billion. Through this strategic move, Jazz Pharmaceuticals is set to expand its offerings with GW's diverse portfolio of cannabinoid products, notably including Epidiolex, the first plant-derived cannabinoid medicine sanctioned by the U.S. FDA. GW Pharmaceuticals plc, based in the US, specializes in the discovery, development, and commercialization of innovative therapeutics primarily targeting chronic visceral pain syndromes.

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grunenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.,

North America was the largest region in the visceral pain market in 2023. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the visceral pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The visceral pain market consists of sales of opioids, anticonvulsants, gabapentin, and pregabalin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Visceral Pain Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on visceral pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for visceral pain? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The visceral pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Drug Class: Calcium Channel Blockers; Nonsteroidal Anti-Inflammatory (NSAID); Other Drug Classes
2) By Indications: Interstitial Cystitis; Crohn's; Irritable Bowel; Chronic Prostatitis; Other Indications
3) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
Companies Mentioned: Walgreens Boots Alliance Inc.; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co.Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r16744

1. Executive Summary

2. Visceral Pain Market Characteristics

3. Visceral Pain Market Trends And Strategies

4. Visceral Pain Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Visceral Pain Market Size and Growth

5.1. Global Visceral Pain Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Visceral Pain Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Visceral Pain Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Visceral Pain Market Segmentation

6.1. Global Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Calcium Channel Blockers
Nonsteroidal Anti-Inflammatory (NSAID)
Other Drug Classes
6.2. Global Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Interstitial Cystitis
Crohn's
Irritable Bowel
Chronic Prostatitis
Other Indications
6.3. Global Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users

7. Visceral Pain Market Regional And Country Analysis

7.1. Global Visceral Pain Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Visceral Pain Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Visceral Pain Market

8.1. Asia-Pacific Visceral Pain Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Visceral Pain Market

9.1. China Visceral Pain Market Overview
9.2. China Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Visceral Pain Market

10.1. India Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Visceral Pain Market

11.1. Japan Visceral Pain Market Overview
11.2. Japan Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Visceral Pain Market

12.1. Australia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Visceral Pain Market

13.1. Indonesia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Visceral Pain Market

14.1. South Korea Visceral Pain Market Overview
14.2. South Korea Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Visceral Pain Market

15.1. Western Europe Visceral Pain Market Overview
15.2. Western Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Visceral Pain Market

16.1. UK Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Visceral Pain Market

17.1. Germany Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Visceral Pain Market

18.1. France Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Visceral Pain Market

19.1. Italy Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Visceral Pain Market

20.1. Spain Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Visceral Pain Market

21.1. Eastern Europe Visceral Pain Market Overview
21.2. Eastern Europe Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Visceral Pain Market

22.1. Russia Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Visceral Pain Market

23.1. North America Visceral Pain Market Overview
23.2. North America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Visceral Pain Market

24.1. USA Visceral Pain Market Overview
24.2. USA Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Visceral Pain Market

25.1. Canada Visceral Pain Market Overview
25.2. Canada Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Visceral Pain Market

26.1. South America Visceral Pain Market Overview
26.2. South America Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Visceral Pain Market

27.1. Brazil Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Visceral Pain Market

28.1. Middle East Visceral Pain Market Overview
28.2. Middle East Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Visceral Pain Market

29.1. Africa Visceral Pain Market Overview
29.2. Africa Visceral Pain Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Visceral Pain Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Visceral Pain Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Visceral Pain Market Competitive Landscape And Company Profiles

30.1. Visceral Pain Market Competitive Landscape
30.2. Visceral Pain Market Company Profiles
- 30.2.1. Walgreens Boots Alliance Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Johnson & Johnson Services Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. F. Hoffmann-La Roche Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck & Co.Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Visceral Pain Market Other Major And Innovative Companies

31.1. AbbVie Inc.
31.2. Novartis AG
31.3. Sanofi SA
31.4. Bristol-Myers Squibb Company
31.5. AstraZeneca PLC
31.6. GlaxoSmithKline PLC
31.7. Takeda Pharmaceutical Company Limited
31.8. Eli Lilly and Company
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Mylan N.V.
31.11. Bausch Health Companies Inc.
31.12. Sun Pharmaceutical Industries Ltd.
31.13. Perrigo Company PLC
31.14. Dr. Reddy's Laboratories Ltd.
31.15. Endo International PLC

32. Global Visceral Pain Market Competitive Benchmarking

33. Global Visceral Pain Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Visceral Pain Market

35. Visceral Pain Market Future Outlook and Potential Analysis

35.1 Visceral Pain Market In 2028 - Countries Offering Most New Opportunities
35.2 Visceral Pain Market In 2028 - Segments Offering Most New Opportunities
35.3 Visceral Pain Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer